Safer Chemicals Podcast | Highlights from the March 2022 Risk Assessment and Socio-Economic Analysis committees

Description

This episode gives you the highlights from the first 2022 meetings of the Committees for Risk Assessment (RAC) and Socio-Economic Analysis (SEAC). We interviewed the Chairs of the two committees, Tim Bowmer (RAC) and Maria Ottati (SEAC).

Both Committees are made up of scientists nominated by EU Member States but appointed by the management Board of ECHA in their personal capacity and both have observers from different EU organisations representing civil society, academia and industry. They are responsible for making scientific opinions that are then used by the European Commission and EU member states when deciding how chemical risks need to be controlled.

You will hear about opinions on harmonised classification and labelling proposals, restrictions and applications for authorisation. We also talk about the use of human bio-monitoring to protect workers from exposure to harmful chemicals and much more.

Give us feedback

More

**************

Visit our website

Disclaimer: Views expressed by interviewees do not necessarily represent the official position of the European Chemicals Agency. All content is up to date at the time of publication.

Hosted by Ausha. See ausha.co/privacy-policy for more information.

Chapters

Read more about the committees' March meetings.
Chapter link•
00:00
RAC opinion on Dechlorane Plus
01:21
Are there viable alternatives for Dechlorane Plus?
05:03
SEAC opinion on Dechlorane Plus
06:48
Why is it not possible to quantify the benefits for Dechlorane Plus?
10:48
What harmonised classification and labelling proposals were on RAC's agenda?
11:52
What cancer classification was given to multi-walled carbon nanotubes?
14:29
What are the main uses of multi-walled carbon nanotubes?
15:14
Harmonised classification and labelling proposal for Sulphur.
16:10
What are the next steps for these proposals?
19:54
What were the two occupational exposure limits (OELs) discussed by the committee?
21:05
What is the SEAC's working group on qualitative assessment and how will it help the work of the committee?
22:41
What is the difference between qualitative and quantitative assessment in the work of SEAC? Can you give an example?
25:11
Why is it expected that the need for qualitative assessment will increase for cases covering a wide range of substances, sectors or uses?
26:05
Anything to highlight from the applications for authorisation discussed in SEAC? (Kasper Walter case)
27:13
RAC guidance on the use of human biomonitoring in applications for authorisation to protect workers.
30:29

Description

**************

Hosted by Ausha. See ausha.co/privacy-policy for more information.

Chapters

Read more about the committees' March meetings.
Chapter link•
00:00
RAC opinion on Dechlorane Plus
01:21
Are there viable alternatives for Dechlorane Plus?
05:03
SEAC opinion on Dechlorane Plus
06:48
Why is it not possible to quantify the benefits for Dechlorane Plus?
10:48
What harmonised classification and labelling proposals were on RAC's agenda?
11:52
What cancer classification was given to multi-walled carbon nanotubes?
14:29
What are the main uses of multi-walled carbon nanotubes?
15:14
Harmonised classification and labelling proposal for Sulphur.
16:10
What are the next steps for these proposals?
19:54
What were the two occupational exposure limits (OELs) discussed by the committee?
21:05
What is the SEAC's working group on qualitative assessment and how will it help the work of the committee?
22:41
What is the difference between qualitative and quantitative assessment in the work of SEAC? Can you give an example?
25:11
Why is it expected that the need for qualitative assessment will increase for cases covering a wide range of substances, sectors or uses?
26:05
Anything to highlight from the applications for authorisation discussed in SEAC? (Kasper Walter case)
27:13
RAC guidance on the use of human biomonitoring in applications for authorisation to protect workers.
30:29

Embed

Copy link